pharma antitrust


Pfizer Completes $5.4 Billion Acquisition of Sickle Cell Disease Drug Innovator

Pfizer Inc. has acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company whose leading product inhibits harmful medical conditions that lead to the relatively rare…